Cargando…
Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
BACKGROUND: Vascular endothelial growth factor (VEGF) is a critical regulator of malignant pleural effusion (MPE) in non-small-cell lung cancer (NSCLC). Bevacizumab (BEV) and apatinib (APA) are novel VEGF blockers that inhibit lung cancer cell proliferation and the development of pleural effusion. M...
Autores principales: | Xiang, Zhangqiang, Deng, Xiangyu, He, Wenfeng, Yang, Qian, Ni, Laichao, Dehghan Shasaltaneh, Marzieh, Maghsoudloo, Mazaher, Yang, Gang, Wu, Jingbo, Imani, Saber, Wen, Qinglian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103356/ https://www.ncbi.nlm.nih.gov/pubmed/35543207 http://dx.doi.org/10.1080/07853890.2022.2071977 |
Ejemplares similares
-
Genome-wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis
por: Zou, Linglin, et al.
Publicado: (2020) -
Comparative mRNA/micro-RNA co-expression network drives melanomagenesis by promoting epithelial–mesenchymal transition and vasculogenic mimicry signaling
por: He, WenFeng, et al.
Publicado: (2021) -
Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy
por: Guo, Rui, et al.
Publicado: (2022) -
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer
por: Yang, Gang, et al.
Publicado: (2021) -
The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis
por: Zhang, Zhenhua, et al.
Publicado: (2019)